Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole-body turbo STIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655–1661. https://doi.org/10.2214/ajr.169.6.9393186

Article  CAS  PubMed  Google Scholar 

Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, Yucel EK, Patriquin L, Eustace S (2000) Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11(4):343–350. https://doi.org/10.1002/(sici)1522-2586(200004)11:4%3c343:aid-jmri1%3e3.0.co;2-p

Article  CAS  PubMed  Google Scholar 

Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18(9):1937–1952. https://doi.org/10.1007/s00330-008-0968-z

Article  PubMed  PubMed Central  Google Scholar 

Summers P, Saia G, Colombo A, Pricolo P, Zugni F, Alessi S, Marvaso G, Jereczek-Fossa BA, Bellomi M, Petralia G (2021) Whole-body magnetic resonance imaging: technique, guidelines and key applications. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2021.1164

Article  PubMed  PubMed Central  Google Scholar 

Morone M, Bali MA, Tunariu N, Messiou C, Blackledge M, Grazioli L, Koh DM (2017) Whole-body MRI: current applications in oncology. AJR Am J Roentgenol 209(6):W336–W349. https://doi.org/10.2214/AJR.17.17984

Article  PubMed  Google Scholar 

Tunariu N, Blackledge M, Messiou C, Petralia G, Padhani A, Curcean S, Curcean A, Koh DM (2020) What’s new for clinical whole-body MRI (WB-MRI) in the 21st century. Br J Radiol 93(1115):20200562. https://doi.org/10.1259/bjr.20200562

Article  PubMed  PubMed Central  Google Scholar 

Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S (2019) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 20(6):e302–e312. https://doi.org/10.1016/S1470-2045(19)30309-2.Erratum.In:LancetOncol.2019Jul;20(7):e346. (PMID: 31162104)

Article  PubMed  Google Scholar 

Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U (2021) EHA Guidelines Committee. ESMO guidelines committee multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):309–322. https://doi.org/10.1016/j.annonc.2020.11.014

Article  CAS  PubMed  Google Scholar 

NICE guideline [NG35] Myeloma: diagnosis and management. Published: 10 February 2016 Last updated: 25 October 2018

Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, Lai M, Pratt G (2017) British society for haematology guidelines. Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol 178(3):380–393. https://doi.org/10.1111/bjh.14827

Article  PubMed  Google Scholar 

Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, Tombal B, Gillessen S (2020) ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(9):1119–1134. https://doi.org/10.1016/j.annonc.2020.06.011

Article  CAS  PubMed  Google Scholar 

Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA (2020) Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol 38(17):1963–1996. https://doi.org/10.1200/JCO.19.02757

Article  CAS  PubMed  Google Scholar 

Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D (2013) German society of dermatology S3-guideline “diagnosis, therapy and follow-up of melanoma” short version. J Dtsch Dermatol Ges 11(6):563–602. https://doi.org/10.1111/ddg.12044

Article  PubMed  Google Scholar 

Dummer R, Siano M, Hunger RE, Lindenblatt N, Braun R, Michielin O, Mihic-Probst D, von Moos R, Najafi Y, Guckenberger M, Arnold A (2016) The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly 146:w14279. https://doi.org/10.4414/smw.2016.14279

Article  PubMed  Google Scholar 

Li B, Li Q, Nie W, Liu S (2014) Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol 83(2):338–344. https://doi.org/10.1016/j.ejrad.2013.11.017

Article  PubMed  Google Scholar 

Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23(11):e38–e45. https://doi.org/10.1158/1078-0432.CCR-17-0408. (PMID: 28572266)

Article  CAS  PubMed  Google Scholar 

Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugières L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23(11):e32–e37. https://doi.org/10.1158/1078-0432.CCR-17-0574. (PMID: 28572265)

Article  PubMed  Google Scholar 

Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD (2017) Von hippel-lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23(12):e68–e75. https://doi.org/10.1158/1078-0432.CCR-17-0547. (PMID: 28620007)

Article  CAS  PubMed  Google Scholar 

Blackledge MD, Tunariu N, Zugni F, Holbrey R, Orton MR, Ribeiro A, Hughes JC, Scurr ED, Collins DJ, Leach MO, Koh DM (2020) Noise-corrected, exponentially weighted, diffusion-weighted MRI (niceDWI) improves image signal uniformity in whole-body imaging of metastatic prostate cancer. Front Oncol 8(10):704. https://doi.org/10.3389/fonc.2020.00704

Article  Google Scholar 

Busacchio D, Mazzoni D, Mazzocco K, Pricolo P, Summers PE, Petralia G, Pravettoni G (2023) Psychological characteristics and satisfaction for the whole-body MRI in cancer screening. Psychol Health Med 28(2):548–554. https://doi.org/10.1080/13548506.2022.2126989

Article  PubMed  Google Scholar 

Madl JE, Sturmbauer SC, Janka R, Bay S, Rohleder N (2022) Preparing patients according to their individual coping style improves patient experience of magnetic resonance imaging. J Behav Med 45(6):841–854. https://doi.org/10.1007/s10865-022-00361-y

Article  PubMed  PubMed Central  Google Scholar 

Mazzocco K, Busacchio D, Summers PE, Marzorati C, Pricolo P, Petralia G, Pravettoni G (2023) Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? Cancer Rep (Hoboken) 6(3):e1737. https://doi.org/10.1002/cnr2.1737

Article  PubMed  Google Scholar 

Ahlander BM, Årestedt K, Engvall J, Maret E, Ericsson E (2016) Development and validation of a questionnaire evaluating patient anxiety during magnetic resonance imaging: the magnetic resonance imaging-anxiety questionnaire (MRI-AQ). J Adv Nurs 72(6):1368–1380. https://doi.org/10.1111/jan.12917

Article  PubMed  Google Scholar 

Harris LM, Cumming SR, Menzies RG (2004) Predicting anxiety in magnetic resonance imaging scans. Int J Behav Med 11(1):1–7. https://doi.org/10.1207/s15327558ijbm1101_1

Article  PubMed  Google Scholar 

Eshed I, Althoff CE, Hamm B, Hermann KG (2007) Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 26(2):401–404. https://doi.org/10.1002/jmri.21012

Article  PubMed  Google Scholar 

Gabr RE, Narayana PA (2016). Patient Distraction and Entertainment System for Magnetic Resonance Imaging using Visual Effects Synchronized to the Scanner Acoustic Noise.

Oztek MA, Brunnquell CL, Hoff MN, Boulter DJ, Mossa-Basha M, Beauchamp LH, Haynor DL, Nguyen XV (2020) Practical considerations for radiologists in implementing a patient-friendly MRI experience. Top Magn Reson Imaging 29(4):181–186. https://doi.org/10.1097/RMR.0000000000000247

Article  PubMed  Google Scholar 

Földes Z, Ala-Ruona E, Burger B, Orsi G (2017) Anxiety reduction with music and tempo synchronization on magnetic reson